Literature DB >> 17594911

The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.

Emilie Huet1, François Boulay, Sophie Barral, Marie-Josèphe Rabiet.   

Abstract

The N-formyl peptide receptor-like 1 (FPRL1) is a G protein-coupled receptor (GPCR) that transmits intracellular signals in response to a variety of agonists, many of them being clearly implicated in human pathology. beta-arrestins are adaptor proteins that uncouple GPCRs from G protein and regulate receptor internalization. They can also function as signal transducers through the scaffolding of signaling molecules, such as components of the extracellular signal-regulated kinase (ERK) cascade. We investigated the role of beta-arrestins in ligand-induced FPRL1 internalization and signaling. In HEK293 cells expressing FPRL1, fluorescence microscopy revealed that agonist-stimulated FPRL1 remained co-localized with beta-arrestins during endocytosis. Internalization of FPRL1, expressed in a mouse embryonic fibroblast (MEF) cell line lacking endogenous beta-arrestins, was highly compromised. This distinguishes FPRL1 from the prototypical formyl peptide receptor FPR that is efficiently internalized in the absence of beta-arrestins. In both HEK293 and MEF cells, FPRL1-mediated ERK1/2 activation was a rapid and transient event. The kinetics and extent of ERK1/2 activation were not significantly modified by beta-arrestin overexpression. The pattern of FPRL1-mediated ERK1/2 activation was similar whether cells express or not beta-arrestins. Furthermore, treatment of the FPRL1 expressing cells with pertussis toxin inhibited ERK1/2 activation in MEF and in HEK293 cells. These results led us to conclude that activation of ERK1/2 mediated by FPRL1 occurs primarily through G protein signaling. Since beta-arrestin-mediated signaling has been observed essentially for receptors coupled to G proteins other than G(i), this may be a characteristic of G(i) protein-coupled chemoattractant receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594911     DOI: 10.1016/j.cellsig.2007.05.006

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  16 in total

1.  Activated human hydroxy-carboxylic acid receptor-3 signals to MAP kinase cascades via the PLC-dependent PKC and MMP-mediated EGFR pathways.

Authors:  Q Zhou; G Li; X Y Deng; X B He; L J Chen; C Wu; Y Shi; K P Wu; L J Mei; J X Lu; N M Zhou
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

2.  Formyl peptide receptor-mediated ERK1/2 activation occurs through G(i) and is not dependent on beta-arrestin1/2.

Authors:  Jeannie M Gripentrog; Heini M Miettinen
Journal:  Cell Signal       Date:  2007-11-09       Impact factor: 4.315

3.  FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.

Authors:  Paola Maderna; David C Cottell; Tiina Toivonen; Neil Dufton; Jesmond Dalli; Mauro Perretti; Catherine Godson
Journal:  FASEB J       Date:  2010-06-22       Impact factor: 5.191

Review 4.  Neutrophil Signaling That Challenges Dogmata of G Protein-Coupled Receptor Regulated Functions.

Authors:  Claes Dahlgren; André Holdfeldt; Simon Lind; Jonas Mårtensson; Michael Gabl; Lena Björkman; Martina Sundqvist; Huamei Forsman
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-11

5.  Distinct kinetic and spatial patterns of protein kinase C (PKC)- and epidermal growth factor receptor (EGFR)-dependent activation of extracellular signal-regulated kinases 1 and 2 by human nicotinic acid receptor GPR109A.

Authors:  Guo Li; Xiaoyan Deng; Chun Wu; Qi Zhou; Linjie Chen; Ying Shi; Haishan Huang; Naiming Zhou
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

6.  N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.

Authors:  Marie-Josèphe Rabiet; Laurence Macari; Claes Dahlgren; François Boulay
Journal:  J Biol Chem       Date:  2011-05-04       Impact factor: 5.157

Review 7.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

8.  The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase.

Authors:  André Holdfeldt; Sarah Line Skovbakke; Malene Winther; Michael Gabl; Christina Nielsen; Iris Perez-Gassol; Camilla Josephine Larsen; Ji Ming Wang; Anna Karlsson; Claes Dahlgren; Huamei Forsman; Henrik Franzyk
Journal:  J Biol Chem       Date:  2016-07-15       Impact factor: 5.157

9.  Gi-dependent cell signaling responses of the human P2Y14 receptor in model cell systems.

Authors:  Ingrid P Fricks; Rhonda L Carter; Eduardo R Lazarowski; T Kendall Harden
Journal:  J Pharmacol Exp Ther       Date:  2009-04-01       Impact factor: 4.030

10.  A novel fluorescent cross-reactive formylpeptide receptor/formylpeptide receptor-like 1 hexapeptide ligand.

Authors:  J Jacob Strouse; Susan M Young; Hugh D Mitchell; Richard D Ye; Eric R Prossnitz; Larry A Sklar; Bruce S Edwards
Journal:  Cytometry A       Date:  2009-03       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.